Last reviewed · How we verify
NCT03146884
Swiss Autoimmune Hepatitis Cohort Study
trial in Hepatitis, Autoimmune in 500 participants. Currently enrolling.
31 December 2030
Quick facts
| Lead sponsor | Fondazione Epatocentro Ticino |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 16 February 2017 |
| Primary completion | 31 December 2030 |
| Estimated completion | 31 December 2030 |
| Sites | 20 locations across Switzerland |
Conditions studied
- Hepatitis, Autoimmune — all drugs for Hepatitis, Autoimmune →
- Autoimmune Hepatitis — all drugs for Autoimmune Hepatitis →
Sponsor
Fondazione Epatocentro Ticino
Who can join
Eligibility, any sex, with Hepatitis, Autoimmune or Autoimmune Hepatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03146884
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatitis, Autoimmune
Currently open trials in the same condition.
- NCT02997878 — Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH · Phase 1, PHASE2 · active not recruiting
Other Fondazione Epatocentro Ticino trials
Trials by the same sponsor.
- NCT04635605 — Methylene Blue Treatment of COVID-19 · Phase 2 · completed
- NCT03146936 — Swiss Primary Sclerosing Cholangitis Cohort Study · recruiting
- NCT03146910 — Swiss Primary Biliary Cholangitis Cohort Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03146884 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Epatocentro Ticino
- Last refreshed: 18 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03146884.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing